EU Deal Cheers Switzerland As Local Medtechs Drive For Regulatory Progress On Three Tracks
Swiss-EU Agreement Signals Likely Progress Of Medtech MRA
Switzerland’s devices MRA with the EU is fully back on the agenda following a broader, historic EU-Swiss future trade deal agreed on 20 December. Additionally, Swiss Medtech is pursuing MDR improvements with EU counterparts, and the Swiss authorities will lay the ground in 2025 to permit US FDA-approved in Switzerland.
